{"prompt": "['CONFIDENTIAL', '201112 (EPI-NTHI-001 BOD APA)', 'Protocol Amendment 3 Final', '6.4.2.6.', 'Pregnancy test (Amended 19 October 2018)', 'Female subjects of childbearing potential are to have a urine pregnancy test prior to any', 'study procedure. Note: The urine pregnancy test must be performed even if the subject is', 'menstruating at the time of the study visit.', '6.4.2.7.', 'Measure/ record height and weight', 'The height and weight of the subject will be measured at Visit 3 and recorded in the', \"'Physical examination' section of the eCRF.\", '6.4.2.8.', 'Pre- and post-bronchodilator spirometry', 'Pre- and post-bronchodilator spirometry should be performed during Visit 3 as detailed in', 'Table 4. Only study-certified staff can perform spirometry assessment for this study.', 'Spirometry will be performed following the eResearchTechnology (ERT) instructions for', 'use FlowScreen manual and following all safety requirements.', 'A good quality spirometry should be obtained, and will be confirmed by the spirometry', 'provider. If during Visit 3 a good quality spirometry was not obtained, the spirometry can', \"be repeated, as per investigator's medical judgement. If a repeat spirometry is elected, the\", 'site should make all possible efforts to repeat the spirometry preferably within 7 days of', 'the previous spirometry. The data will be directly transferred from the provider to GSK', 'Biologicals.', 'Treatment of any abnormality observed during spirometry has to be performed according', 'to local medical practice outside this study or by referral to an appropriate health care', 'provider.', '6.4.2.9.', \"Record subject's COPD status\", \"The subject's COPD status (stable/recovered or not recovered) will be recorded in the\", 'eCRF.', '6.4.2.10.', 'Record current medication (Amended 19 October 2018)', 'At each study visit/contact, the investigator should question the subject about any', 'medications taken.', 'All medications administered will be recorded in the eCRF.', '6.4.2.11. Record healthcare resource utilisation', \"Healthcare use will be obtained through review of the subject's medical record (aided by\", 'subject self-reporting). Healthcare utilisation includes all unscheduled visits to a', 'physician office, visits to urgent care, visits to emergency department, and', 'hospitalizations. Healthcare use should be recorded in eDiary Card and reported in the', '19-OCT-2018', '48', '75661ebdab2e949f7a1f1bc2071b9dec72aceccf']['CONFIDENTIAL', '201112 (EPI-NTHI-001 BOD APA)', 'Protocol Amendment 3 Final', 'eCRF at study visit. Refer to the SPM for more details and guidance on recording of', 'healthcare use.', '6.4.2.12. Additional treatments prescribed by primary and secondary care', 'physician', 'All treatments prescribed by the primary and secondary healthcare physician will be', 'recorded in the eCRF.', '6.4.2.13.', 'Train subjects on the use of electronic Diary Card and assign electronic', 'Diary Card to subject', 'From screening visit to visit 1, subjects will be trained on how to use their electronic', 'Diary Card. At visit 1, the investigator should evaluate whether or not the subject', 'will be able to comply with the daily completion of the electronic Diary Card', 'throughout the study. Compliance with electronic Diary Card completion implies', 'that subject learns how to translate his/ her respiratory symptoms in answers to the', 'questions as well as acquiring the technical expertise to use the device. Refer to the', 'SPM for recommendations on what is considered adequate compliance.', 'The site staff will follow electronic Diary Card completion closely and should', 'provide timely input/guidance to ensure that the subject reaches the targeted learning', 'curve.', 'In addition, site staff will pro-actively monitor electronic Diary Card compliance', 'throughout the study and provide the necessary input to maintain compliance.', '6.4.2.14. Return the electronic diary card', 'On the last visit (Visit 3), the site staff will pro-actively check with the subjects on', 'whether he/she has returned the electronic Diary Card.', '6.4.2.15.', 'Sputum sampling (Amended 19 October 2018)', 'Sputum samples will be collected during the scheduled visits, if in the opinion of the', 'investigator, it is safe for the subject.', 'Sputum samples can be either spontaneous or induced, as per investigator judgement.', 'Internal standard operating procedures should be put in place to ensure proper', 'sputum collection, sample tracking and subject safety at study collection site.', 'At home, sputum collection will not be permitted.', 'Collected sputum will be diluted in DTT, processed and cultured within 6hrs of', 'collection for microbiology testing', 'Remaining DTT-sputum will be aliquoted as such. These samples will be kept at', '-70/80\u00b0C until shipment to GSK or GSK designated lab for testing.', 'Refer to the SPM and the Central Laboratory Investigator Manual for more details and', 'guidance on handling of sputum samples.', '19-OCT-2018', '49', '75661ebdab2e949f7a1f1bc2071b9dec72acecct']\n\n###\n\n", "completion": "END"}